Pieris Pharmaceuticals Stock Market Value

PIRS Stock  USD 0.19  0.01  5.56%   
Pieris Pharmaceuticals' market value is the price at which a share of Pieris Pharmaceuticals trades on a public exchange. It measures the collective expectations of Pieris Pharmaceuticals investors about its performance. Pieris Pharmaceuticals is selling for under 0.19 as of the 28th of March 2024; that is 5.56 percent up since the beginning of the trading day. The stock's lowest day price was 0.18.
With this module, you can estimate the performance of a buy and hold strategy of Pieris Pharmaceuticals and determine expected loss or profit from investing in Pieris Pharmaceuticals over a given investment horizon. Check out Pieris Pharmaceuticals Correlation, Pieris Pharmaceuticals Volatility and Pieris Pharmaceuticals Alpha and Beta module to complement your research on Pieris Pharmaceuticals.
For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.
Symbol

Pieris Pharmaceuticals Price To Book Ratio

Is Pieris Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pieris Pharmaceuticals. If investors know Pieris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pieris Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
0.564
Quarterly Revenue Growth
2.635
Return On Assets
(0.17)
Return On Equity
(0.85)
The market value of Pieris Pharmaceuticals is measured differently than its book value, which is the value of Pieris that is recorded on the company's balance sheet. Investors also form their own opinion of Pieris Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pieris Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pieris Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pieris Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pieris Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pieris Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pieris Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pieris Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pieris Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pieris Pharmaceuticals.
0.00
02/27/2024
No Change 0.00  0.0 
In 31 days
03/28/2024
0.00
If you would invest  0.00  in Pieris Pharmaceuticals on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Pieris Pharmaceuticals or generate 0.0% return on investment in Pieris Pharmaceuticals over 30 days. Pieris Pharmaceuticals is related to or competes with Agilent Technologies, and Mediwound. Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs More

Pieris Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pieris Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pieris Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Pieris Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pieris Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pieris Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Pieris Pharmaceuticals historical prices to predict the future Pieris Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pieris Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.195.12
Details
Intrinsic
Valuation
LowRealHigh
0.091.886.81
Details
Naive
Forecast
LowNextHigh
00.185.12
Details
1 Analysts
Consensus
LowTargetHigh
6.377.007.77
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pieris Pharmaceuticals. Your research has to be compared to or analyzed against Pieris Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Pieris Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pieris Pharmaceuticals.

Pieris Pharmaceuticals Backtested Returns

Pieris Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0407, which implies the firm had a 0.0407% return per unit of risk over the last 3 months. We have found thirty technical indicators for Pieris Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Pieris Pharmaceuticals' Coefficient Of Variation of 1066.98, risk adjusted performance of 0.061, and Semi Deviation of 3.04 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pieris Pharmaceuticals holds a performance score of 3. The company holds a Beta of 0.29, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pieris Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pieris Pharmaceuticals is expected to be smaller as well. Please check Pieris Pharmaceuticals' sortino ratio and the relationship between the semi variance and relative strength index , to make a quick decision on whether Pieris Pharmaceuticals' historical price patterns will revert.

Auto-correlation

    
  0.19  

Very weak predictability

Pieris Pharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between Pieris Pharmaceuticals time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pieris Pharmaceuticals price movement. The serial correlation of 0.19 indicates that over 19.0% of current Pieris Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.19
Spearman Rank Test0.29
Residual Average0.0
Price Variance0.0

Pieris Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Pieris Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pieris Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Pieris Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Pieris Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Pieris Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pieris Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pieris Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pieris Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Pieris Pharmaceuticals Lagged Returns

When evaluating Pieris Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pieris Pharmaceuticals stock have on its future price. Pieris Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pieris Pharmaceuticals autocorrelation shows the relationship between Pieris Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Pieris Pharmaceuticals.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pieris Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pieris Pharmaceuticals' short interest history, or implied volatility extrapolated from Pieris Pharmaceuticals options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pieris Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pieris Pharmaceuticals is a strong investment it is important to analyze Pieris Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pieris Pharmaceuticals' future performance. For an informed investment choice regarding Pieris Stock, refer to the following important reports:
Check out Pieris Pharmaceuticals Correlation, Pieris Pharmaceuticals Volatility and Pieris Pharmaceuticals Alpha and Beta module to complement your research on Pieris Pharmaceuticals.
For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Pieris Stock analysis

When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pieris Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pieris Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...